殷偉賢
振興醫療財團法人振興醫院
醫療副院長
殷偉賢看診時間
| 星期一 | 24 小時營業 |
| 星期二 | 24 小時營業 |
| 星期三 | 24 小時營業 |
| 星期四 | 24 小時營業 |
| 星期五 | 24 小時營業 |
| 星期六 | 24 小時營業 |
| 星期日 | 24 小時營業 |
殷偉賢醫師簡介
現職
振興醫院醫療副院長
國立陽明大學醫學系部定教授
歐洲心臟學院院士 (FESC)
國立陽明大學醫學系部定教授
歐洲心臟學院院士 (FESC)
學歷
．國立陽明大學臨床醫學博士
．國防醫學院醫學系79期畢業
．國防醫學院醫學系79期畢業
經歷
．振興醫院心臟醫學中心心臟血管內科主任
．振興醫院心臟內科主治醫師
．桃園榮民總醫院內科主治醫師
．台北榮民總醫院內科部特約醫師
．台北榮總心臟內科主治醫師
．台北榮總內科住院醫師、總醫師
．振興醫院心臟內科主治醫師
．桃園榮民總醫院內科主治醫師
．台北榮民總醫院內科部特約醫師
．台北榮總心臟內科主治醫師
．台北榮總內科住院醫師、總醫師
專長
．複雜心導管治療手術，包括冠狀動脈氣球導管擴張術(PTCA)、血管支架裝置術(stenting)、冠狀動脈旋磨術(Rotablation)、左主幹及血管完全閉塞(Chronic total occlusion)治療等。
．複雜結構性心臟病(Structural heart disease)治療，包括經導管主動脈瓣膜植入術(TAVI)、經導管先天及後天性心臟病治療等。
．心臟節律器(Pacemaker)之裝置及追蹤。
．胸前及食道心臟超音波(Transthoracic and Transesophageal Echocardiography)、心電圖檢查。
．心臟循環學(Cardiology)、急診及重症加護醫學(Emergency and Intensive Care)。
．複雜結構性心臟病(Structural heart disease)治療，包括經導管主動脈瓣膜植入術(TAVI)、經導管先天及後天性心臟病治療等。
．心臟節律器(Pacemaker)之裝置及追蹤。
．胸前及食道心臟超音波(Transthoracic and Transesophageal Echocardiography)、心電圖檢查。
．心臟循環學(Cardiology)、急診及重症加護醫學(Emergency and Intensive Care)。
其他
著作發表
REFERRED PAPER:（*為通訊作者）
1. Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Cheng Chang K, Wang JH, Wu CC, Chen JW. Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease. J Formos Med Assoc 2019;118:721-9. (SCI)
2. Ho SK, Wu YW, Tseng WK, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Yeh HI, Wu CC, Chen JW. The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease. Sci Rep 2018;8:14410. Erratum in: Sci Rep 2019;9:4838. (SCI)
3. Wu JR, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention. Sci Rep 2019;9:3091. (SCI)
4. Chang HY, Feng AN, Fong MC, Chong E, Yin WH*. Managements and outcomes of hospitalized heart failure patients with paroxysmal vs nonparoxysmal atrial fibrillation in Taiwan. J Chin Med Assoc 2019;82:356-62. (SCI)
5. Jong CB, Li HY, Pan SL, Hsieh MY, Su FY, Chen KC, Yin WH, Chan SH, Wu YW, Wang KY, Chang KC, Hwang JJ, Wu CC. Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome. J Am Heart Assoc 2019;8:e011215. (SCI)
6. Hsu CY, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Chou RH, Huang CY, Huang PH, Leu HB, Yin WH, Wu CC, Lin SJ, Chen JW. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease. Arterioscler Thromb Vasc Biol 2019;39:1240-52. (SCI)
7. Chang HY, Feng AN, Fong MC, Hsueh CW, Lai WT, Huang KC, Chong E, Chen CN, Chang HC, Yin WH*. Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation. J Cardiol 2019;74:372-80. (SCI)
8. Tzeng YH, Wei J, Tsao TP, Lee YT, Lee KC, Liou HR, Sung HJ, Huang KC, Hsiung MC, Yin WH*. Computed Tomography-Determined Muscle Quality Rather Than Muscle Quantity Is a Better Determinant of Prolonged Hospital Length of Stay in Patients Undergoing Transcatheter Aortic Valve Implantation. Acad Radiol 2020;27:381-8. (SCI)
9. Akdogan RE, Srialluri S, Abdelsalam MGA, Hsiung MC, Nanda NC, Fadala H, Yin WH. Incremental value of right parasternal transthoracic echocardiographic examination over the left parasternal approach in assessing ascending aorta size: Additional benefit of three-dimensional echocardiography. Echocardiography 2019;36:1306-14. (SCI)
10. Wang CC, Wu CK, Tsai ML, Lee CM, Huang WC, Chou HH, Huang JL, Chi NH, Yen HW, Tzeng BH, Chang WT, Chang HY, Wang CH, Lu YY, Tsai JP, Su CH, Cherng WJ, Yin WH, Tsai CT, Wu YW, Lin JL, Hwang JJ. 2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure. Acta Cardiol Sin 2019;35:244-83. (SCI)
11. Huang KC, Yin WH, Lee YT, Tsao TP, Lee KC, Hsiung MC, Wei J. Quantification of Stent Creep by Three-Dimensional Transesophageal Echocardiography in Patients Undergoing Transcatheter Aortic Valve-in-Valve Implantation for Failed Bioprostheses. Acta Cardiol Sin 2019;35:380-6. (SCI)
12. Chang HY, Chen KC, Fong MC, Feng AN, Fu HN, Huang KC, Chong E, Yin WH*. Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management. J Cardiol 2020;75:233-41. (SCI)
13. Tzeng YH, Lee YT, Tsao TP, Lee KC, Huang KC, Hsiung MC, Wei J, Yin WH*. Performance and short-term outcomes of three different transcatheter aortic valve replacement devices in patients with aortic stenosis: A single-center experience. J Chin Med Assoc 2019;82:827-34. (SCI)
14. Huang WP, Yin WH, Chen JS, Huang PH, Chen JW, Lin SJ. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure. J Cardiovasc Transl Res 2020;13:158-170. (SCI)
15. Tsai HS, Tseng WK, Yin WH, Lin FJ, Hsuan CF, Wu YW, Huang LC, Lin TH, Chang KC, Li YH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. The Correlation between Waist-Hip Ratio and Achieving Therapeutic Lipid Goals in Taiwan. Acta Cardiol Sin 2019;35:605-14. (SCI)
16. Chang HY, Su YW, Feng AN, Fong MC, Huang KC, Chong E, Chen KC, Yin WH*. Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction. ESC Heart Fail 2020;7:604-615. (SCI)
17. Wu YW, Ho SK, Tseng WK, Yeh HI, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Wu CC, Chen JW. Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease. Sci Rep 2020;10:5638. (SCI)
18. Huang CC, Chang MT, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Shyur LF, Chen JW. Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease. Sci Rep 2020;10:8105. (SCI)
19. Zhang JJ, Ye F, Xu K, Kan J, Tao L, Santoso T, Munawar M, Tresukosol D, Li L, Sheiban I, Li F, Tian NL, Rodríguez AE, Paiboon C, Lavarra F, Lu S, Vichairuangthum K, Zeng H, Chen L, Zhang R, Ding S, Gao F, Jin Z, Hong L, Ma L, Wen S, Wu X, Yang S, Yin WH, Zhang J, Wang Y, Zheng Y, Zhou L, Zhou L, Zhu Y, Xu T, Wang X, Qu H, Tian Y, Lin S, Liu L, Lu Q, Li Q, Li B, Jiang Q, Han L, Gan G, Yu M, Pan D, Shang Z, Zhao Y, Liu Z, Yuan Y, Chen C, Stone GW, Han Y, Chen SL. Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial. Eur Heart J 2020;41:2523-2536. (SCI)
20. Chiang CE, Ueng KC, Chao TH, Lin TH, Wu YJ, Wang KL, Sung SH, Yeh HI, Li YH, Liu PY, Chang KC, Shyu KG, Huang JL, Tsai CD, Hung HF, Liu ME, Chao TF, Cheng SM, Cheng HM, Chu PH, Yin WH, Wu YW, Chen WJ, Lai WT, Lin SJ, Yeh SJ, Hwang JJ. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases. J Chin Med Assoc 2020;83:587-621. (SCI)
21. Tay EL, Hayashida K, Chen M, Yin WH, Park DW, Seth A, Kao HL, Lin MS, Ho KW, Buddhari W, Chandavimol M, Posas FE, Nguyen QN, Kong W, Rosli MA, Hon J, Firman D, Lee M. Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia. J Card Surg 2020;35:2142-2146. (SCI)
22. Lai WT, Hsiung MC, Lin LC, Yin WH, Hsu CH, Huang KC. Stepwise manipulation of cardiac computed tomography multi-planar reconstruction to mimic transesophageal echocardiography. Echocardiography 2020;37:1512-1523. (SCI)
23. Li YH, Tseng WK, Yin WH, Lin FJ, Wu YW, Hsieh IC, Lin TH, Sheu WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment. Sci Rep 2020;10:21835. (SCI)
24. Tsai HY, Wu YW, Tseng WK, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Yeh HI, Wu CC, Chen JW; National Taiwan Biosignature Research Investigators. Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions. J Formos Med Assoc 2021;120:728-736. (SCI)
25. Park H, Kang DY, Ahn JM, Kim KW, Wong AYT, Lam SCC, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Ko E, Kim DH, Koo HJ, Yang DH, Kang JW, Jung SC, Lee JH, Yun SC, Park SJ, Park DW. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement. BMJ Open 2021;11:e042587. (SCI)
26. Chiam PTL, Hayashida K, Watanabe Y, Yin WH, Kao HL, Lee MKY, Posas FE, Chandavimol M, Buddhari W, Dy TC, Nguyen NQ, Kim WJ, Chang K, Lin MS, Lam YY, Pham HM, Yahaya SA, Ho KW, Pan W, Liu XB, Wang J, Kim HS, Chen M. Sex differences in patients undergoing transcatheter aortic valve replacement in Asia. Open Heart 2021;8:e001541.
27. Huang WP, Yin WH, Chen JS, Huang PH, Chen JW, Lin SJ. Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway. Sci Rep 2021;11:1159. (SCI)
28. Liu PY, Su CH, Kuo FY, Lee WL, Wang YC, Lin WS, Chu PH, Lu TM, Lo PH, Lee CH, Lan WR, Huang CL, Tsukiyama S, Yang WC, Cheng LC, Rafael V, Nikolajsen C, Yin WH*. Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy. Cardiovasc Interv Ther 2022;37:269-278. Erratum in: Cardiovasc Interv Ther 2022;37:279-280.
29. Yang YL, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Adherence to healthy lifestyle improved clinical outcomes in coronary artery disease patients after coronary intervention. J Chin Med Assoc 2021;84:596-605. (SCI)
30. Hsiung MC, Yin WH, Lee YT, Tsao TP, Lee KC, Huang KC, Chen PE, Chiang WH, Tung TH, Wei J. Effects of Transapical Transcatheter Mitral Valve Implantation. Front Cardiovasc Med 2021;8:633369. (SCI)
31. Jen HL, Wang YC, Tsao TP, Yin WH*. Percutaneous Coronary Intervention for Very Small Vessels With the Use of a Newer-Generation 2.0 mm Drug-Eluting Stent. J Invasive Cardiol 2021;33:E565-E574. (SCI)
32. Fong MC, Chang HY, Wang CC, Feng AN, Lin WS, Wu YW, Sung SH, Huang JL, Kuo JY, Yin WH. The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure Medications. Acta Cardiol Sin 2021;37:394-403. (SCI)
33. Wang WT, Wu TC, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Leu HB, Yin WH, Wu CC, Chen JW. Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease. Medicine 2021;100:48(e27973). (SCI)
34. Chiang CE, Ueng KC, Chao TH, Lin TH, Wu YJ, Wang KL, Sung SH, Yeh HI, Li YH, Liu PY, Chang KC, Shyu KG, Huang JL, Tsai CD, Hung HF, Liu ME, Chao TF, Cheng SM, Cheng HM, Chu PH, Yin WH, Wu YW, Chen WJ, Lai WT, Lin SJ, Yeh SJ, Hwang JJ, Hou CJ. 2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes. JACC: Asia 2021;1:129-146.
35. Lin WC, Hsiung MC, Yin WH, Tsao TP, Lai WT, Huang KC. Electrocardiography Score for Left Ventricular Systolic Dysfunction in Non-ST Segment Elevation Acute Coronary Syndrome. Front Cardiovasc Med 2022;8:764575. (SCI)
36. Lien CC, Yin WH, Yang DM, Chen LK, Chen CW, Liu SY, Kwok CF, Ho LT, Juan CC. Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca2+/ERK/CaMKIII pathway in 3T3-L1 adipocytes. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159071. (SCI) (共同第一作者)
37. Hsuan CF, Lin FJ, Lee TL, Yang KC, Tseng WK, Wu YW, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease. Sci Rep 2022;12:804. (SCI)
38. Yin WH, Lee YT, Tsao TP, Lee KC, Hsiung MC, Wei J. Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices. Ann Transl Med 2022;10:24. (SCI)
39. Tay E, Khaing T, Yin WH, Posas EF, Kao PH, Buddhari W, Hayashida K, Ho KW, Lin MS, Yap J, Zhang JJ, Chiam PTL, Rosli MA, Park SJ, Udayacherm W, Yanagisawa R, Tan HC, Lee MKY. Asia Pacific TAVI registry (an APSIC initiative): initial report of early outcomes: Asia Pacific TAVI registry. AsiaIntervention 2021;7:54-59.
40. Lai WT, Yu HP, Lin CC, Yin WH, Ko TY, Hwang JJ, Lin LC, Huang KC. Right Ventricular Pump Efficiency in Secundum-Type Atrial Septal Defect. Acta Cardiol Sin 2022;38:47-55. (SCI)
41. Kuo FY, Lee CH, Lan WR, Su CH, Lee WL, Wang YC, Lin WS, Chu PH, Lu TM, Lo PH, Tsukiyama S, Yang WC, Cheng LC, Huang CL, Yin WH, Liu PY. Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study. J Formos Med Assoc 2022;121:1786-1797. (SCI)
42. Park DW, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Lee SA, Ko E, Park H, Kim DH, Kang JW, Lee JH, Park SJ. Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. Circulation 2022;146:466-479. (SCI)
43. Hong JS, Tzeng YH, Yin WH, Wu KT, Hsu HY, Lu CF, Liu HR, Wu YT. Automated coronary artery calcium scoring using nested U-Net and focal loss. Comput Struct Biotechnol J 2022;20:1681-1690. (SCI)
44. Lee YT, Yin WH*, Tsao TP, Lee KC, Hsiung MC, Tzeng YH, Wei J. The Presence of Calcified Raphe Is an Independent Predictor of Adverse Long-Term Clinical Outcomes in Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. Front Cardiovasc Med 2022;9:767906. (SCI)
45. Tzeng YH, Yin WH*, Lin KC, Wei J, Liou HR, Sung HJ, Lang HC*. Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel Analysis. J Med Internet Res 2022;24:e40288. (SCI) (共同通訊作者)
46. Kong Ho S, Leu HB, Wu CC, Yeh HI, Yin WH, Lin TH, Chang KC, Wang JH, Tseng WK, Chen JW, Wu YW. The prognostic significance of the presence of tenascin-C in patients with stable coronary heart disease. Clin Chim Acta 2022;535:68-74. (SCI)
47. Cheng CC, Lin CS, Yin WH, Lin C, Liu IF, Lee YF, Liu WT, Fu HN, Huang CL, Tsao TP. The safety and efficacy of the Mo.Ma system device for carotid artery stenting: A single-center experience from Taiwan. Front Cardiovasc Med 2022;9:926513. (SCI)
48. Tan EC, Lee YT, Kuo YC, Tsao TP, Lee KC, Hsiung MC, Wei J, Lin KC, Yin WH*. Clinical outcomes and cumulative healthcare costs of TAVR vs. SAVR in Asia. Front Cardiovasc Med 2022;9:973889. (SCI) (共同通訊作者)
49. Lee WL, Wang YC, Su CS, Lee HF, Tung YC, Liu PY, Su CH, Kuo FY, Lin WS, Chu PH, Lu TM, Lo PH, Tsukiyama S, Yang WC, Cheng LC, Yin WH*, Lin YH. A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study. Acta Cardiol Sin 2022;38:751-764. (SCI) (共同通訊作者)
50. Lin YH, Tsai CH, Chiang CE, Kuo JY, Yin WH, Wen MS, Lo PH, Liu PY, Lin TH, Chen ZC, Shyu KG, Hung MJ, Hwang JJ, Tseng CD. The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure. Acta Cardiol Sin 2022;38:700-713. (SCI)
51. Cheong KI, Leu HB, Wu CC, Yin WH, Wang JH, Lin TH, Tseng WK, Chang KC, Chu SH, Yeh HI, Chen JW, Wu YW; National Taiwan Biosignature Research Investigators. The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease. J Formos Med Assoc 2023;122:328-337. (SCI)
52. Elmarzouky ZM, Hsiung MC, Darwish A, Dulal S, Maturi B, Yin WH, Lee YT, Tsao TP, Wei J, Nanda NC. Utilization of Two- and Three-Dimensional Transesophageal Echocardiography in Successfully Guiding Transcatheter Mitral Valve in Bioprosthetic Mitral Valve/Mitral Ring Implantation without Complications in Patients with Thrombus in Left Atrium/Left Atrial Appendage. J Clin Med 2022;11:7084. (SCI)
53. Liu PY, Lin FJ, Yeh CF, Hsiao YC, Hsuan CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators. Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan. J Clin Med 2023;12:2162. (SCI)
54. Chiang CE, Hung CL, Wu YW, Lin TH, Ueng KC, Sung SH, Wu CK, Chao TH, Lin HJ, Lin YH, Huang JL, Chen MYC, Lin PL, Chao TF, Cheng HM, Liu ME, Wang TD, Yeh HI, Li YH, Liu PY, Yin WH, Hsieh IC, Wang CC, Chen CH, Chu PH, Lin SJ, Yeh SJ, Lin JL, Hwang JJ, Hung HF, Chen WJ, Hou CJ. 2023 Consensus of Taiwan Society of Cardiology on the Pharmacological Treatment of Chronic Heart Failure. Acta Cardiol Sin 2023;39:361-390. (SCI)
55. Lee JH, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Ko E, Park H, Lee SA, Kim DH, Park SJ, Park DW; ADAPT-TAVR Investigators. Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial. Am J Cardiol 2023;203:352-361. (SCI)
56. Hsiao YC, Lee TL, Lin FJ, Hsuan CF, Yeh CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WHH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators. A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD. Biomed J 2023 Aug 12:100653. doi: 10.1016/j.bj.2023.100653. (SCI)
57. Jang MH, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Ko E, Lee SA, Kim DH, Kim H, Choi Y, Lee J, Park SJ, Park DW. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement. Heart 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946. (SCI)
58. Kao TW, Huang CC, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Inflammation and renal function decline in chronic coronary syndrome: a prospective multicenter cohort study. BMC Cardiovasc Disord 2023;23:564. (SCI)
59. Kim M, Ahn JM, Kang DY, Kim MJ, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Yu Ko T, Kim WJ, Kang SH, Lee SA, Ko E, Kim DH, Kang JW, Lee JH, Lee J, Park J, Kim H, Choi Y, Park SJ, Park DW. Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial. Am Heart J 2024;269:167-178. (SCI)
60. Choi Y, Ahn JM, Kang DY, Kim HJ, Kim H, Lee J, Kim M, Park J, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Anthony Wong YT, Simon Lam CC, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Lee SA, Kim DH, Lee JH, Park SJ, Park DW; ADAPT-TAVR Investigators. Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2023;16:2967-2981. (SCI)
61. Ko SL, Hung CL, Chen CN, Tsao TP, Fong MC, Yin WH, Chang HY. Effects of Mask Wearing on Treadmill Exercise Test. Am J Cardiol 2024;213:161-163. (SCI)
62. Armario X, Carron J, Simpkin AJ, Elhadi M, Kennedy C, Abdel-Wahab M, Bleiziffer S, Lefèvre T, Wolf A, Pilgrim T, Villablanca PA, Blackman DJ, Van Mieghem NM, Hengstenberg C, Swaans MJ, Prendergast BD, Patterson T, Barbanti M, Webb JG, Behan M, Resar J, Chen M, Hildick-Smith D, Spence MS, Zweiker D, Bagur R, Teles R, Ribichini FL, Jagielak D, Park DW, Kornowski R, Wykrzykowska JJ, Bunc M, Estévez-Loureiro R, Poon K, Götberg M, Jeger RV, Ince H, Packer EJS, Angelillis M, Nombela-Franco L, Guo Y, Savontaus M, Al-Moghairi AM, Parasca CA, Kliger C, Roy D, Molnár L, Silva M, White J, Yamamoto M, Carrilho-Ferreira P, Toggweiler S, Voudris V, Ohno Y, Rodrigues I, Parma R, Ojeda S, Toutouzas K, Regueiro A, Grygier M, AlMerri K, Cruz-González I, Fridrich V, de la Torre Hernández JM, Noble S, Kala P, Asmarats L, Kurt IH, Bosmans J, Erglis M, Casserly I, Iskandarani D, Bhindi R, Kefer J, Yin WH, Rosseel L, Kim HS, O'Connor S, Hellig F, Sztejfman M, Mendiz O, Pineda AM, Seth A, Pllaha E, de Brito FS Jr, Bajoras V, Balghith MA, Lee M, Eid-Lidt G, Vandeloo B, Vaz VD, Alasnag M, Ussia GP, Tay E, Mayol J, Gunasekaran S, Sardella G, Buddhari W, Kao HL, Dager A, Tzikas A, Gudmundsdottir IJ, Edris A, Gutiérrez Jaikel LA, Arias EA, Al-Hijji M, Ertürk M, Conde-Vela C, Boljević D, Ferrero Guadagnoli A, Hermlin T, ElGuindy AM, Lima-Filho MO, de Moura Santos L, Perez L, Maluenda G, Akyüz AR, Alhaddad IA, Amin H, So CY, Al Nooryani AA, Vaca C, Albistur J, Nguyen QN, Arzamendi D, Grube E, Modine T, Tchétché D, Hayashida K, Latib A, Makkar RR, Piazza N, Søndergaard L, McEvoy JW, Mylotte D. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study. JACC Cardiovasc Interv 2024;17:374-387. (SCI)
63. Yeh JT, Huang CC, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Fatty acid-binding protein-3 and renal function decline in patients with chronic coronary syndrome. Clin Cardiol 2024;47:e24210. (SCI)
64. Huang CL, Tsao TP, Yin WH, Huang WB, Jen HL, Lin CC, Chang CY, Hsu CH. Comprehensive comparative efficacy and safety of potent P2Y12 inhibitors in patients undergoing coronary intervention: A systematic review and meta-analysis. Int J Cardiol Heart Vasc 2024;51:101359. (SCI)
REVIEW ARTICLES:
1.Chang HY, Yin WH. Response to "Grey Areas and Open Questions in Neprilysin Inhibition". J Cardiol 2020;75:463-4. (SCI) (Letter to the Editor)
2.Yin WH, Lee YT, Tsao TP, Wei J. Delayed Coronary Obstruction after Transcatheter Aortic Valve Replacement - An Uncommon But Serious Complication. Acta Cardiol Sin 2020;36:409-415.
3.Xiong TY, Ali WB, Feng Y, Hayashida K, Jilaihawi H, Latib A, Lee MK, Leon MB, Makkar RR, Modine T, Naber C, Peng Y, Piazza N, Reardon MJ, Redwood S, Seth A, Sondergaard L, Tay E, Tchetche D, Yin WH, Chen M, Prendergast B, Mylotte D. Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization. Nat Rev Cardiol 2023;20:52-67. (SCI)
4.Ling AJ, Lee YT, Yin WH*. Binodal Disease after a Hornet Bee Sting. Acta Cardiol Sin 2023;39:773-775. (SCI) (Letter to the Editor)
CASE REPORT:
1. Fong MC, Feng AN, Yin WH, Tsao TP, Chang HY. Defibrillation therapies following sodium-glucose cotransporter 2 inhibitor treatment: A report of two cases. HeartRhythm Case Rep 2021;7:338-42.
2. Lin HC, Lee YT, Tsao TP, Yin WH*. A valve embolized twice: a case report of Sapien 3 embolization in left ventricle and left atrium during transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis. Eur Heart J Case Rep 2023;7:ytad357. (SCI)
3. Lin HC, Lee YT, Yin WH, Wei J. A case report of transcatheter closure of post-Bentall ascending aortic pseudoaneurysm due to coronary button dehiscence. Eur Heart J Case Rep 2023;7:ytad516. (SCI)
CO-INVESTIGATORS OF MAJOR CLINICAL TRIALS:
1.Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators (…, Yin WH,….). Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med 2018;379:2097-107. (SCI)
2.Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators (…, Yin WH,….). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol 2019;7:618-28. (SCI)
3.Ntaios G, Huisman MV, Diener HC, Halperin JL, Teutsch C, Marler S, Gurusamy VK, Thompson M, Lip GYH, Olshansky B; GLORIA-AF Investigators (…, Yin WH,….). Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry. Hellenic J Cardiol 2021;62:152-7. (SCI)
4.Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG; ODYSSEY OUTCOMES Committees and Investigators (…,Yin WH,…). Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. Diabetes Care 2021;44:1219-27. (SCI)
5.Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators (…,Yin WH,…). Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. J Am Coll Cardiol 2021;78:421-33. (SCI)
6.Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators (…,Yin WH,…). Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry. Clin Res Cardiol 2022;111:560-573. Erratum in: Clin Res Cardiol 2022;111:593. (SCI)
7.Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators (…,Yin WH,…). Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation 2022;146:657-672. (SCI)
8.Ding WY, Fawzy AM, Romiti GF, Proietti M, Pastori D, Huisman MV, Lip GYH; GLORIA-AF Investigators (…,Yin WH,…). Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. J Thromb Thrombolysis 2023 Aug 11. doi: 10.1007/s11239-023-02866-y. Erratum in: J Thromb Thrombolysis. 2023 Oct 9;: (SCI)
9.Romiti GF, Corica B, Proietti M, Mei DA, Frydenlund J, Bisson A, Boriani G, Olshansky B, Chan YH, Huisman MV, Chao TF, Lip GYH; GLORIA-AF Investigators (…,Yin WH,…). Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry. EClinicalMedicine 2023;63:102039. (SCI)
CONFERENCE PAPER:
1. Yin WH. Management strategies for this complication type. (Abstract) 2019; Singapore Live 2019.
2. Yin WH. How to start and grow a TAVI program? (Abstract) 2019; CSI ASIA-PACIFIC 2019.
3. Yin WH. J-Valve for the treatment of aortic valve stenosis and regurgitation. (Abstract) 2019; CSI ASIA-PACIFIC 2019.
4. Yin WH. Special considerations for bicuspid aortic stenosis using balloon expandable valves. (Abstract) 2019; CSI ASIA-PACIFIC 2019.
5. Yin WH. Experience of Heart Failure Treatment in Taiwan. (Abstract) 2019; CIT 2019.
6. Yin WH. Concomitant Transcatheter Heart Valve Replacement and Occluder Repair for Structural Valve Failure and Paravalvular Leakage in Surgical Bioprosthesis. (Abstract) 2019; CIT 2019.
7. Yin WH. Case Presentation: TAVR by Extremely Difficult Femoral Artery Approach. (Abstract) 2019; CIT 2019.
8. Yin WH. Current Status of TAVR in Taiwan. (Abstract) 2019; CIT 2019.
9. Yin WH. Factors of TAVR in Elderly Patients. (Abstract) 2019; CIT 2019.
10. Yin WH. Case Review, Tips and Tricks. (Abstract) 2019; China Valve Hangzhou 2019.
11. Yin WH. New Devices and Techniques - Sapien 3. (Abstract) 2019; China Valve Hangzhou 2019.
12. Yin WH. Consideration of TAVR in low risk patients. (Abstract) 2019; The 13th Oriental Congress of Cardiology.
13. Yin WH. Tricks and trips of balloon expanding valve and management of untypical case. (Abstract) 2019; The 13th Oriental Congress of Cardiology.
14. Yin WH. TAVI: recent update and concerns? (Abstract) 2019; Structural Cardiac Intervention 2019.
15. Yin WH. PCI in CHIP patients declined by cardiac surgeons. (Abstract) 2019; ENCORE SEOUL 2019.
16. Yin WH. PCI after TAVR: Techniques and tips. (Abstract) 2019; ENCORE SEOUL 2019.
17. Yin WH. The Advances in Pharmacy Therapy of HF. (Abstract) 2019; GW-ICC 2019.
18. Yin WH. TAVR in Patients with Pure Aortic Valve Regurgitation. (Abstract) 2019; GW-ICC 2019.
19. Yin WH. Real World Experience with Entresto in Heart Failure Patients from Taiwan. (Abstract) 2019; GW-ICC 2019.
20. Yin WH. Edwards Sapien 3: Technology overview and case example. (Abstract) 2019; 2019 PCR-CIT China Chengdu Valves.
21. Yin WH. Diabetic patients with abnormal ECG: when and who needed referrals for catheterization? (Abstract) 2019; The 11th International Association of Gerontology and Geriatrics Asia/Oceania Regional Congress.
22. Yin WH. Saving Coronary Artery: TAVR-related Coronary Obstruction. (Abstract) 2019; Complex PCI 2019.
23. Yin WH. Clinical outcomes after TAVI in bicuspid aortic valves: what do we know? (Abstract) 2023; PCR Tokyo Valves 2023.
24. Yin WH. Learn from Masters: Optimizing TAVI Outcomes - Refinements of Balloon expandable TAVR. (Abstract) 2023; China Valve Hangzhou 2023.
25. Yin WH. Coronary risk management of transcatheter aortic valve replacement. (Abstract) 2023; The 17th Oriental Congress of Cardiology.
26. Yin WH. Transcatheter treatment for failed surgical bioprostheses. (Abstract) 2023; The 17th Oriental Congress of Cardiology.
27. Yin WH. Current Status of TAVI in Taiwan. (Abstract) 2023; The 31st Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT 2023).
28. Yin WH. Master's Case 3: Repeated Recurrent Restenosis in a Patient with Delayed Coronary Obstruction after TAVR. (Abstract) 2023; AP VALVES & STRUCTURAL HEART 2023.
29. Yin WH. Sharing Experiences on Why I Choose SAPIEN 3 for a Better Outcome. (Abstract) 2023; AP VALVES & STRUCTURAL HEART 2023.
30. Yin WH. What can we do to overcome complex case? (Abstract) 2023; ENCORE SEOUL 2023.
31. Yin WH. How to manage balloon uncrossable or undilated lesion - From microcatheter to lithotripsy. (Abstract) 2023; ENCORE SEOUL 2023.
32. Yin WH. Tips and tricks of TAVI in failed transcatheter bioprosthesis. (Abstract) 2023; PCR-CIT China Chengdu Valves 2023.
33. Yin WH. Transfemoral access for TAVI: advanced techniques for better results (echo-guided puncture, shockwave). (Abstract) 2023; PCR-CIT China Chengdu Valves 2023.
34. Yin WH, Lee YT, Tsao TP, Wei J. Thirty-day Remote Electrocardiogram Screening in Patients undergoing Transcatheter Aortic Valve Replacement. (Abstract) 2023; PCR London Valves 2023.
35. Yin WH. Transcatheter treatment of failed mitral bioprosthesis. (Abstract) 2023; APCASH 2023.
36. Yin WH. 2024 Updates in the Management of CHIP Patients: Addressing the high-risk valvular patient with comorbid coronary disease. (Abstract) 2024; Singapore LIVE 2024.
37. Yin WH. Mastering techniques from basic to complex - TAVI basics: vascular access and closure. (Abstract) 2024; PCR Tokyo Valves 2024.
38. Yin WH, Lee YT, Lin HC, Tsao TP, Lee KC, Hsiung MC, Wei J. Proper sizing improves procedural outcomes of TAVR with both balloon-expandable and self-expanding valves for bicuspid aortic valve stenosis. (Abstract) 2024; PCR Tokyo Valves 2024.
39. Yin WH. Sizzling Contemporary Issues in Structural Heart Disease - How to Determine Optimal Implantation Depth in TAVR. (Abstract) 2024; MIS-Korea 2024.
40. Yin WH. Tips and Tricks in Bicuspid AS TAVR. (Abstract) 2024; China Valve Hangzhou 2024.
41. Yin WH. How to Treat Degenerated TAVI Valve? (Abstract) 2024; 29th TCTAP 2024.
42. Yin WH, Lee YT, Lee KC, Tsao TP, Wei J. Proper Sizing Takes into Consideration of Annular and Supra-Annular Planes and Calcium Distribution Can Improve Outcomes of Transcatheter Aortic Valve Replacement with Both Balloon-Expandable and Self-Expanding Valves. (Abstract) 2024; 29th TCTAP 2024.
43. Yin WH. LAMPOON technique improves outcomes of Transcatheter mitral valve-in-valve and valve-in-ring. (Abstract) 2024; EuroPCR 2024.
44. Yin WH. Next generation of TAVR procedure-ViV-TAVR and Redo-TAVR. (Abstract) 2024; The 18th Oriental Congress of Cardiology Together with The World Congress of Cardiology 2024.
45. Yin WH. Applications of LAMPOON Technology for TMVR. (Abstract) 2024; The 18th Oriental Congress of Cardiology Together with The World Congress of Cardiology 2024.
46. Yin WH. Patient management before during and after transcatheter tricuspid intervention. (Abstract) 2024; Beijing Valves 2024.
47. Yin WH. Breaking barriers between physicians and surgeons in the era of valve intervention therapy. (Abstract) 2024; Beijing Valves 2024.
48. Yin WH. Coronary-first Approach to Optimize Results of TAVR and Redo-TAVR. (Abstract) 2024; AP VALVES & STRUCTURAL HEART 2024.
中文著作:
1. 殷偉賢. 台灣心衰治療現狀. 福建省醫學會心血管病學分會第二十三次心血管病學術會議, 2019. (摘要)
2. 殷偉賢. TAVR使用於較年輕病人應考慮的事項. 福建省醫學會心血管病學分會第二十三次心血管病學術會議, 2019. (摘要)
3. 殷偉賢. 外科醫師婉拒的高危CHIP PCI. 海峽兩岸醫藥衛生交流協會心血管專業委員會第十屆年會, 2019. (摘要)
4. 殷偉賢. 二尖瓣膜閉鎖不全治療的新境界-Transcatheter mitral valve replacement: what is new? 臺灣醫學會第116屆總會, 2023. (摘要)
5. 賴旻, 邱尚志, 李佩珍, 殷偉賢, 林寬佳. 台灣小區域民眾就醫經驗之分析. 台灣衛誌 2023;42:651-662.
REFERRED PAPER:（*為通訊作者）
1. Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Cheng Chang K, Wang JH, Wu CC, Chen JW. Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease. J Formos Med Assoc 2019;118:721-9. (SCI)
2. Ho SK, Wu YW, Tseng WK, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Yeh HI, Wu CC, Chen JW. The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease. Sci Rep 2018;8:14410. Erratum in: Sci Rep 2019;9:4838. (SCI)
3. Wu JR, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention. Sci Rep 2019;9:3091. (SCI)
4. Chang HY, Feng AN, Fong MC, Chong E, Yin WH*. Managements and outcomes of hospitalized heart failure patients with paroxysmal vs nonparoxysmal atrial fibrillation in Taiwan. J Chin Med Assoc 2019;82:356-62. (SCI)
5. Jong CB, Li HY, Pan SL, Hsieh MY, Su FY, Chen KC, Yin WH, Chan SH, Wu YW, Wang KY, Chang KC, Hwang JJ, Wu CC. Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome. J Am Heart Assoc 2019;8:e011215. (SCI)
6. Hsu CY, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Chou RH, Huang CY, Huang PH, Leu HB, Yin WH, Wu CC, Lin SJ, Chen JW. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease. Arterioscler Thromb Vasc Biol 2019;39:1240-52. (SCI)
7. Chang HY, Feng AN, Fong MC, Hsueh CW, Lai WT, Huang KC, Chong E, Chen CN, Chang HC, Yin WH*. Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation. J Cardiol 2019;74:372-80. (SCI)
8. Tzeng YH, Wei J, Tsao TP, Lee YT, Lee KC, Liou HR, Sung HJ, Huang KC, Hsiung MC, Yin WH*. Computed Tomography-Determined Muscle Quality Rather Than Muscle Quantity Is a Better Determinant of Prolonged Hospital Length of Stay in Patients Undergoing Transcatheter Aortic Valve Implantation. Acad Radiol 2020;27:381-8. (SCI)
9. Akdogan RE, Srialluri S, Abdelsalam MGA, Hsiung MC, Nanda NC, Fadala H, Yin WH. Incremental value of right parasternal transthoracic echocardiographic examination over the left parasternal approach in assessing ascending aorta size: Additional benefit of three-dimensional echocardiography. Echocardiography 2019;36:1306-14. (SCI)
10. Wang CC, Wu CK, Tsai ML, Lee CM, Huang WC, Chou HH, Huang JL, Chi NH, Yen HW, Tzeng BH, Chang WT, Chang HY, Wang CH, Lu YY, Tsai JP, Su CH, Cherng WJ, Yin WH, Tsai CT, Wu YW, Lin JL, Hwang JJ. 2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure. Acta Cardiol Sin 2019;35:244-83. (SCI)
11. Huang KC, Yin WH, Lee YT, Tsao TP, Lee KC, Hsiung MC, Wei J. Quantification of Stent Creep by Three-Dimensional Transesophageal Echocardiography in Patients Undergoing Transcatheter Aortic Valve-in-Valve Implantation for Failed Bioprostheses. Acta Cardiol Sin 2019;35:380-6. (SCI)
12. Chang HY, Chen KC, Fong MC, Feng AN, Fu HN, Huang KC, Chong E, Yin WH*. Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management. J Cardiol 2020;75:233-41. (SCI)
13. Tzeng YH, Lee YT, Tsao TP, Lee KC, Huang KC, Hsiung MC, Wei J, Yin WH*. Performance and short-term outcomes of three different transcatheter aortic valve replacement devices in patients with aortic stenosis: A single-center experience. J Chin Med Assoc 2019;82:827-34. (SCI)
14. Huang WP, Yin WH, Chen JS, Huang PH, Chen JW, Lin SJ. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure. J Cardiovasc Transl Res 2020;13:158-170. (SCI)
15. Tsai HS, Tseng WK, Yin WH, Lin FJ, Hsuan CF, Wu YW, Huang LC, Lin TH, Chang KC, Li YH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. The Correlation between Waist-Hip Ratio and Achieving Therapeutic Lipid Goals in Taiwan. Acta Cardiol Sin 2019;35:605-14. (SCI)
16. Chang HY, Su YW, Feng AN, Fong MC, Huang KC, Chong E, Chen KC, Yin WH*. Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction. ESC Heart Fail 2020;7:604-615. (SCI)
17. Wu YW, Ho SK, Tseng WK, Yeh HI, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Wu CC, Chen JW. Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease. Sci Rep 2020;10:5638. (SCI)
18. Huang CC, Chang MT, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Shyur LF, Chen JW. Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease. Sci Rep 2020;10:8105. (SCI)
19. Zhang JJ, Ye F, Xu K, Kan J, Tao L, Santoso T, Munawar M, Tresukosol D, Li L, Sheiban I, Li F, Tian NL, Rodríguez AE, Paiboon C, Lavarra F, Lu S, Vichairuangthum K, Zeng H, Chen L, Zhang R, Ding S, Gao F, Jin Z, Hong L, Ma L, Wen S, Wu X, Yang S, Yin WH, Zhang J, Wang Y, Zheng Y, Zhou L, Zhou L, Zhu Y, Xu T, Wang X, Qu H, Tian Y, Lin S, Liu L, Lu Q, Li Q, Li B, Jiang Q, Han L, Gan G, Yu M, Pan D, Shang Z, Zhao Y, Liu Z, Yuan Y, Chen C, Stone GW, Han Y, Chen SL. Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial. Eur Heart J 2020;41:2523-2536. (SCI)
20. Chiang CE, Ueng KC, Chao TH, Lin TH, Wu YJ, Wang KL, Sung SH, Yeh HI, Li YH, Liu PY, Chang KC, Shyu KG, Huang JL, Tsai CD, Hung HF, Liu ME, Chao TF, Cheng SM, Cheng HM, Chu PH, Yin WH, Wu YW, Chen WJ, Lai WT, Lin SJ, Yeh SJ, Hwang JJ. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases. J Chin Med Assoc 2020;83:587-621. (SCI)
21. Tay EL, Hayashida K, Chen M, Yin WH, Park DW, Seth A, Kao HL, Lin MS, Ho KW, Buddhari W, Chandavimol M, Posas FE, Nguyen QN, Kong W, Rosli MA, Hon J, Firman D, Lee M. Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia. J Card Surg 2020;35:2142-2146. (SCI)
22. Lai WT, Hsiung MC, Lin LC, Yin WH, Hsu CH, Huang KC. Stepwise manipulation of cardiac computed tomography multi-planar reconstruction to mimic transesophageal echocardiography. Echocardiography 2020;37:1512-1523. (SCI)
23. Li YH, Tseng WK, Yin WH, Lin FJ, Wu YW, Hsieh IC, Lin TH, Sheu WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment. Sci Rep 2020;10:21835. (SCI)
24. Tsai HY, Wu YW, Tseng WK, Leu HB, Yin WH, Lin TH, Chang KC, Wang JH, Yeh HI, Wu CC, Chen JW; National Taiwan Biosignature Research Investigators. Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions. J Formos Med Assoc 2021;120:728-736. (SCI)
25. Park H, Kang DY, Ahn JM, Kim KW, Wong AYT, Lam SCC, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Ko E, Kim DH, Koo HJ, Yang DH, Kang JW, Jung SC, Lee JH, Yun SC, Park SJ, Park DW. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement. BMJ Open 2021;11:e042587. (SCI)
26. Chiam PTL, Hayashida K, Watanabe Y, Yin WH, Kao HL, Lee MKY, Posas FE, Chandavimol M, Buddhari W, Dy TC, Nguyen NQ, Kim WJ, Chang K, Lin MS, Lam YY, Pham HM, Yahaya SA, Ho KW, Pan W, Liu XB, Wang J, Kim HS, Chen M. Sex differences in patients undergoing transcatheter aortic valve replacement in Asia. Open Heart 2021;8:e001541.
27. Huang WP, Yin WH, Chen JS, Huang PH, Chen JW, Lin SJ. Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway. Sci Rep 2021;11:1159. (SCI)
28. Liu PY, Su CH, Kuo FY, Lee WL, Wang YC, Lin WS, Chu PH, Lu TM, Lo PH, Lee CH, Lan WR, Huang CL, Tsukiyama S, Yang WC, Cheng LC, Rafael V, Nikolajsen C, Yin WH*. Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy. Cardiovasc Interv Ther 2022;37:269-278. Erratum in: Cardiovasc Interv Ther 2022;37:279-280.
29. Yang YL, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Adherence to healthy lifestyle improved clinical outcomes in coronary artery disease patients after coronary intervention. J Chin Med Assoc 2021;84:596-605. (SCI)
30. Hsiung MC, Yin WH, Lee YT, Tsao TP, Lee KC, Huang KC, Chen PE, Chiang WH, Tung TH, Wei J. Effects of Transapical Transcatheter Mitral Valve Implantation. Front Cardiovasc Med 2021;8:633369. (SCI)
31. Jen HL, Wang YC, Tsao TP, Yin WH*. Percutaneous Coronary Intervention for Very Small Vessels With the Use of a Newer-Generation 2.0 mm Drug-Eluting Stent. J Invasive Cardiol 2021;33:E565-E574. (SCI)
32. Fong MC, Chang HY, Wang CC, Feng AN, Lin WS, Wu YW, Sung SH, Huang JL, Kuo JY, Yin WH. The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure Medications. Acta Cardiol Sin 2021;37:394-403. (SCI)
33. Wang WT, Wu TC, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Leu HB, Yin WH, Wu CC, Chen JW. Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease. Medicine 2021;100:48(e27973). (SCI)
34. Chiang CE, Ueng KC, Chao TH, Lin TH, Wu YJ, Wang KL, Sung SH, Yeh HI, Li YH, Liu PY, Chang KC, Shyu KG, Huang JL, Tsai CD, Hung HF, Liu ME, Chao TF, Cheng SM, Cheng HM, Chu PH, Yin WH, Wu YW, Chen WJ, Lai WT, Lin SJ, Yeh SJ, Hwang JJ, Hou CJ. 2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes. JACC: Asia 2021;1:129-146.
35. Lin WC, Hsiung MC, Yin WH, Tsao TP, Lai WT, Huang KC. Electrocardiography Score for Left Ventricular Systolic Dysfunction in Non-ST Segment Elevation Acute Coronary Syndrome. Front Cardiovasc Med 2022;8:764575. (SCI)
36. Lien CC, Yin WH, Yang DM, Chen LK, Chen CW, Liu SY, Kwok CF, Ho LT, Juan CC. Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca2+/ERK/CaMKIII pathway in 3T3-L1 adipocytes. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159071. (SCI) (共同第一作者)
37. Hsuan CF, Lin FJ, Lee TL, Yang KC, Tseng WK, Wu YW, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease. Sci Rep 2022;12:804. (SCI)
38. Yin WH, Lee YT, Tsao TP, Lee KC, Hsiung MC, Wei J. Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices. Ann Transl Med 2022;10:24. (SCI)
39. Tay E, Khaing T, Yin WH, Posas EF, Kao PH, Buddhari W, Hayashida K, Ho KW, Lin MS, Yap J, Zhang JJ, Chiam PTL, Rosli MA, Park SJ, Udayacherm W, Yanagisawa R, Tan HC, Lee MKY. Asia Pacific TAVI registry (an APSIC initiative): initial report of early outcomes: Asia Pacific TAVI registry. AsiaIntervention 2021;7:54-59.
40. Lai WT, Yu HP, Lin CC, Yin WH, Ko TY, Hwang JJ, Lin LC, Huang KC. Right Ventricular Pump Efficiency in Secundum-Type Atrial Septal Defect. Acta Cardiol Sin 2022;38:47-55. (SCI)
41. Kuo FY, Lee CH, Lan WR, Su CH, Lee WL, Wang YC, Lin WS, Chu PH, Lu TM, Lo PH, Tsukiyama S, Yang WC, Cheng LC, Huang CL, Yin WH, Liu PY. Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study. J Formos Med Assoc 2022;121:1786-1797. (SCI)
42. Park DW, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Lee SA, Ko E, Park H, Kim DH, Kang JW, Lee JH, Park SJ. Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. Circulation 2022;146:466-479. (SCI)
43. Hong JS, Tzeng YH, Yin WH, Wu KT, Hsu HY, Lu CF, Liu HR, Wu YT. Automated coronary artery calcium scoring using nested U-Net and focal loss. Comput Struct Biotechnol J 2022;20:1681-1690. (SCI)
44. Lee YT, Yin WH*, Tsao TP, Lee KC, Hsiung MC, Tzeng YH, Wei J. The Presence of Calcified Raphe Is an Independent Predictor of Adverse Long-Term Clinical Outcomes in Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. Front Cardiovasc Med 2022;9:767906. (SCI)
45. Tzeng YH, Yin WH*, Lin KC, Wei J, Liou HR, Sung HJ, Lang HC*. Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel Analysis. J Med Internet Res 2022;24:e40288. (SCI) (共同通訊作者)
46. Kong Ho S, Leu HB, Wu CC, Yeh HI, Yin WH, Lin TH, Chang KC, Wang JH, Tseng WK, Chen JW, Wu YW. The prognostic significance of the presence of tenascin-C in patients with stable coronary heart disease. Clin Chim Acta 2022;535:68-74. (SCI)
47. Cheng CC, Lin CS, Yin WH, Lin C, Liu IF, Lee YF, Liu WT, Fu HN, Huang CL, Tsao TP. The safety and efficacy of the Mo.Ma system device for carotid artery stenting: A single-center experience from Taiwan. Front Cardiovasc Med 2022;9:926513. (SCI)
48. Tan EC, Lee YT, Kuo YC, Tsao TP, Lee KC, Hsiung MC, Wei J, Lin KC, Yin WH*. Clinical outcomes and cumulative healthcare costs of TAVR vs. SAVR in Asia. Front Cardiovasc Med 2022;9:973889. (SCI) (共同通訊作者)
49. Lee WL, Wang YC, Su CS, Lee HF, Tung YC, Liu PY, Su CH, Kuo FY, Lin WS, Chu PH, Lu TM, Lo PH, Tsukiyama S, Yang WC, Cheng LC, Yin WH*, Lin YH. A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study. Acta Cardiol Sin 2022;38:751-764. (SCI) (共同通訊作者)
50. Lin YH, Tsai CH, Chiang CE, Kuo JY, Yin WH, Wen MS, Lo PH, Liu PY, Lin TH, Chen ZC, Shyu KG, Hung MJ, Hwang JJ, Tseng CD. The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure. Acta Cardiol Sin 2022;38:700-713. (SCI)
51. Cheong KI, Leu HB, Wu CC, Yin WH, Wang JH, Lin TH, Tseng WK, Chang KC, Chu SH, Yeh HI, Chen JW, Wu YW; National Taiwan Biosignature Research Investigators. The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease. J Formos Med Assoc 2023;122:328-337. (SCI)
52. Elmarzouky ZM, Hsiung MC, Darwish A, Dulal S, Maturi B, Yin WH, Lee YT, Tsao TP, Wei J, Nanda NC. Utilization of Two- and Three-Dimensional Transesophageal Echocardiography in Successfully Guiding Transcatheter Mitral Valve in Bioprosthetic Mitral Valve/Mitral Ring Implantation without Complications in Patients with Thrombus in Left Atrium/Left Atrial Appendage. J Clin Med 2022;11:7084. (SCI)
53. Liu PY, Lin FJ, Yeh CF, Hsiao YC, Hsuan CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators. Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan. J Clin Med 2023;12:2162. (SCI)
54. Chiang CE, Hung CL, Wu YW, Lin TH, Ueng KC, Sung SH, Wu CK, Chao TH, Lin HJ, Lin YH, Huang JL, Chen MYC, Lin PL, Chao TF, Cheng HM, Liu ME, Wang TD, Yeh HI, Li YH, Liu PY, Yin WH, Hsieh IC, Wang CC, Chen CH, Chu PH, Lin SJ, Yeh SJ, Lin JL, Hwang JJ, Hung HF, Chen WJ, Hou CJ. 2023 Consensus of Taiwan Society of Cardiology on the Pharmacological Treatment of Chronic Heart Failure. Acta Cardiol Sin 2023;39:361-390. (SCI)
55. Lee JH, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Ko E, Park H, Lee SA, Kim DH, Park SJ, Park DW; ADAPT-TAVR Investigators. Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial. Am J Cardiol 2023;203:352-361. (SCI)
56. Hsiao YC, Lee TL, Lin FJ, Hsuan CF, Yeh CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WHH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators. A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD. Biomed J 2023 Aug 12:100653. doi: 10.1016/j.bj.2023.100653. (SCI)
57. Jang MH, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Ko E, Lee SA, Kim DH, Kim H, Choi Y, Lee J, Park SJ, Park DW. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement. Heart 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946. (SCI)
58. Kao TW, Huang CC, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Inflammation and renal function decline in chronic coronary syndrome: a prospective multicenter cohort study. BMC Cardiovasc Disord 2023;23:564. (SCI)
59. Kim M, Ahn JM, Kang DY, Kim MJ, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Yu Ko T, Kim WJ, Kang SH, Lee SA, Ko E, Kim DH, Kang JW, Lee JH, Lee J, Park J, Kim H, Choi Y, Park SJ, Park DW. Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial. Am Heart J 2024;269:167-178. (SCI)
60. Choi Y, Ahn JM, Kang DY, Kim HJ, Kim H, Lee J, Kim M, Park J, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Anthony Wong YT, Simon Lam CC, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Lee SA, Kim DH, Lee JH, Park SJ, Park DW; ADAPT-TAVR Investigators. Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2023;16:2967-2981. (SCI)
61. Ko SL, Hung CL, Chen CN, Tsao TP, Fong MC, Yin WH, Chang HY. Effects of Mask Wearing on Treadmill Exercise Test. Am J Cardiol 2024;213:161-163. (SCI)
62. Armario X, Carron J, Simpkin AJ, Elhadi M, Kennedy C, Abdel-Wahab M, Bleiziffer S, Lefèvre T, Wolf A, Pilgrim T, Villablanca PA, Blackman DJ, Van Mieghem NM, Hengstenberg C, Swaans MJ, Prendergast BD, Patterson T, Barbanti M, Webb JG, Behan M, Resar J, Chen M, Hildick-Smith D, Spence MS, Zweiker D, Bagur R, Teles R, Ribichini FL, Jagielak D, Park DW, Kornowski R, Wykrzykowska JJ, Bunc M, Estévez-Loureiro R, Poon K, Götberg M, Jeger RV, Ince H, Packer EJS, Angelillis M, Nombela-Franco L, Guo Y, Savontaus M, Al-Moghairi AM, Parasca CA, Kliger C, Roy D, Molnár L, Silva M, White J, Yamamoto M, Carrilho-Ferreira P, Toggweiler S, Voudris V, Ohno Y, Rodrigues I, Parma R, Ojeda S, Toutouzas K, Regueiro A, Grygier M, AlMerri K, Cruz-González I, Fridrich V, de la Torre Hernández JM, Noble S, Kala P, Asmarats L, Kurt IH, Bosmans J, Erglis M, Casserly I, Iskandarani D, Bhindi R, Kefer J, Yin WH, Rosseel L, Kim HS, O'Connor S, Hellig F, Sztejfman M, Mendiz O, Pineda AM, Seth A, Pllaha E, de Brito FS Jr, Bajoras V, Balghith MA, Lee M, Eid-Lidt G, Vandeloo B, Vaz VD, Alasnag M, Ussia GP, Tay E, Mayol J, Gunasekaran S, Sardella G, Buddhari W, Kao HL, Dager A, Tzikas A, Gudmundsdottir IJ, Edris A, Gutiérrez Jaikel LA, Arias EA, Al-Hijji M, Ertürk M, Conde-Vela C, Boljević D, Ferrero Guadagnoli A, Hermlin T, ElGuindy AM, Lima-Filho MO, de Moura Santos L, Perez L, Maluenda G, Akyüz AR, Alhaddad IA, Amin H, So CY, Al Nooryani AA, Vaca C, Albistur J, Nguyen QN, Arzamendi D, Grube E, Modine T, Tchétché D, Hayashida K, Latib A, Makkar RR, Piazza N, Søndergaard L, McEvoy JW, Mylotte D. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study. JACC Cardiovasc Interv 2024;17:374-387. (SCI)
63. Yeh JT, Huang CC, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Fatty acid-binding protein-3 and renal function decline in patients with chronic coronary syndrome. Clin Cardiol 2024;47:e24210. (SCI)
64. Huang CL, Tsao TP, Yin WH, Huang WB, Jen HL, Lin CC, Chang CY, Hsu CH. Comprehensive comparative efficacy and safety of potent P2Y12 inhibitors in patients undergoing coronary intervention: A systematic review and meta-analysis. Int J Cardiol Heart Vasc 2024;51:101359. (SCI)
REVIEW ARTICLES:
1.Chang HY, Yin WH. Response to "Grey Areas and Open Questions in Neprilysin Inhibition". J Cardiol 2020;75:463-4. (SCI) (Letter to the Editor)
2.Yin WH, Lee YT, Tsao TP, Wei J. Delayed Coronary Obstruction after Transcatheter Aortic Valve Replacement - An Uncommon But Serious Complication. Acta Cardiol Sin 2020;36:409-415.
3.Xiong TY, Ali WB, Feng Y, Hayashida K, Jilaihawi H, Latib A, Lee MK, Leon MB, Makkar RR, Modine T, Naber C, Peng Y, Piazza N, Reardon MJ, Redwood S, Seth A, Sondergaard L, Tay E, Tchetche D, Yin WH, Chen M, Prendergast B, Mylotte D. Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization. Nat Rev Cardiol 2023;20:52-67. (SCI)
4.Ling AJ, Lee YT, Yin WH*. Binodal Disease after a Hornet Bee Sting. Acta Cardiol Sin 2023;39:773-775. (SCI) (Letter to the Editor)
CASE REPORT:
1. Fong MC, Feng AN, Yin WH, Tsao TP, Chang HY. Defibrillation therapies following sodium-glucose cotransporter 2 inhibitor treatment: A report of two cases. HeartRhythm Case Rep 2021;7:338-42.
2. Lin HC, Lee YT, Tsao TP, Yin WH*. A valve embolized twice: a case report of Sapien 3 embolization in left ventricle and left atrium during transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis. Eur Heart J Case Rep 2023;7:ytad357. (SCI)
3. Lin HC, Lee YT, Yin WH, Wei J. A case report of transcatheter closure of post-Bentall ascending aortic pseudoaneurysm due to coronary button dehiscence. Eur Heart J Case Rep 2023;7:ytad516. (SCI)
CO-INVESTIGATORS OF MAJOR CLINICAL TRIALS:
1.Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators (…, Yin WH,….). Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med 2018;379:2097-107. (SCI)
2.Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators (…, Yin WH,….). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol 2019;7:618-28. (SCI)
3.Ntaios G, Huisman MV, Diener HC, Halperin JL, Teutsch C, Marler S, Gurusamy VK, Thompson M, Lip GYH, Olshansky B; GLORIA-AF Investigators (…, Yin WH,….). Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry. Hellenic J Cardiol 2021;62:152-7. (SCI)
4.Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG; ODYSSEY OUTCOMES Committees and Investigators (…,Yin WH,…). Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. Diabetes Care 2021;44:1219-27. (SCI)
5.Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators (…,Yin WH,…). Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. J Am Coll Cardiol 2021;78:421-33. (SCI)
6.Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators (…,Yin WH,…). Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry. Clin Res Cardiol 2022;111:560-573. Erratum in: Clin Res Cardiol 2022;111:593. (SCI)
7.Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators (…,Yin WH,…). Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation 2022;146:657-672. (SCI)
8.Ding WY, Fawzy AM, Romiti GF, Proietti M, Pastori D, Huisman MV, Lip GYH; GLORIA-AF Investigators (…,Yin WH,…). Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. J Thromb Thrombolysis 2023 Aug 11. doi: 10.1007/s11239-023-02866-y. Erratum in: J Thromb Thrombolysis. 2023 Oct 9;: (SCI)
9.Romiti GF, Corica B, Proietti M, Mei DA, Frydenlund J, Bisson A, Boriani G, Olshansky B, Chan YH, Huisman MV, Chao TF, Lip GYH; GLORIA-AF Investigators (…,Yin WH,…). Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry. EClinicalMedicine 2023;63:102039. (SCI)
CONFERENCE PAPER:
1. Yin WH. Management strategies for this complication type. (Abstract) 2019; Singapore Live 2019.
2. Yin WH. How to start and grow a TAVI program? (Abstract) 2019; CSI ASIA-PACIFIC 2019.
3. Yin WH. J-Valve for the treatment of aortic valve stenosis and regurgitation. (Abstract) 2019; CSI ASIA-PACIFIC 2019.
4. Yin WH. Special considerations for bicuspid aortic stenosis using balloon expandable valves. (Abstract) 2019; CSI ASIA-PACIFIC 2019.
5. Yin WH. Experience of Heart Failure Treatment in Taiwan. (Abstract) 2019; CIT 2019.
6. Yin WH. Concomitant Transcatheter Heart Valve Replacement and Occluder Repair for Structural Valve Failure and Paravalvular Leakage in Surgical Bioprosthesis. (Abstract) 2019; CIT 2019.
7. Yin WH. Case Presentation: TAVR by Extremely Difficult Femoral Artery Approach. (Abstract) 2019; CIT 2019.
8. Yin WH. Current Status of TAVR in Taiwan. (Abstract) 2019; CIT 2019.
9. Yin WH. Factors of TAVR in Elderly Patients. (Abstract) 2019; CIT 2019.
10. Yin WH. Case Review, Tips and Tricks. (Abstract) 2019; China Valve Hangzhou 2019.
11. Yin WH. New Devices and Techniques - Sapien 3. (Abstract) 2019; China Valve Hangzhou 2019.
12. Yin WH. Consideration of TAVR in low risk patients. (Abstract) 2019; The 13th Oriental Congress of Cardiology.
13. Yin WH. Tricks and trips of balloon expanding valve and management of untypical case. (Abstract) 2019; The 13th Oriental Congress of Cardiology.
14. Yin WH. TAVI: recent update and concerns? (Abstract) 2019; Structural Cardiac Intervention 2019.
15. Yin WH. PCI in CHIP patients declined by cardiac surgeons. (Abstract) 2019; ENCORE SEOUL 2019.
16. Yin WH. PCI after TAVR: Techniques and tips. (Abstract) 2019; ENCORE SEOUL 2019.
17. Yin WH. The Advances in Pharmacy Therapy of HF. (Abstract) 2019; GW-ICC 2019.
18. Yin WH. TAVR in Patients with Pure Aortic Valve Regurgitation. (Abstract) 2019; GW-ICC 2019.
19. Yin WH. Real World Experience with Entresto in Heart Failure Patients from Taiwan. (Abstract) 2019; GW-ICC 2019.
20. Yin WH. Edwards Sapien 3: Technology overview and case example. (Abstract) 2019; 2019 PCR-CIT China Chengdu Valves.
21. Yin WH. Diabetic patients with abnormal ECG: when and who needed referrals for catheterization? (Abstract) 2019; The 11th International Association of Gerontology and Geriatrics Asia/Oceania Regional Congress.
22. Yin WH. Saving Coronary Artery: TAVR-related Coronary Obstruction. (Abstract) 2019; Complex PCI 2019.
23. Yin WH. Clinical outcomes after TAVI in bicuspid aortic valves: what do we know? (Abstract) 2023; PCR Tokyo Valves 2023.
24. Yin WH. Learn from Masters: Optimizing TAVI Outcomes - Refinements of Balloon expandable TAVR. (Abstract) 2023; China Valve Hangzhou 2023.
25. Yin WH. Coronary risk management of transcatheter aortic valve replacement. (Abstract) 2023; The 17th Oriental Congress of Cardiology.
26. Yin WH. Transcatheter treatment for failed surgical bioprostheses. (Abstract) 2023; The 17th Oriental Congress of Cardiology.
27. Yin WH. Current Status of TAVI in Taiwan. (Abstract) 2023; The 31st Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT 2023).
28. Yin WH. Master's Case 3: Repeated Recurrent Restenosis in a Patient with Delayed Coronary Obstruction after TAVR. (Abstract) 2023; AP VALVES & STRUCTURAL HEART 2023.
29. Yin WH. Sharing Experiences on Why I Choose SAPIEN 3 for a Better Outcome. (Abstract) 2023; AP VALVES & STRUCTURAL HEART 2023.
30. Yin WH. What can we do to overcome complex case? (Abstract) 2023; ENCORE SEOUL 2023.
31. Yin WH. How to manage balloon uncrossable or undilated lesion - From microcatheter to lithotripsy. (Abstract) 2023; ENCORE SEOUL 2023.
32. Yin WH. Tips and tricks of TAVI in failed transcatheter bioprosthesis. (Abstract) 2023; PCR-CIT China Chengdu Valves 2023.
33. Yin WH. Transfemoral access for TAVI: advanced techniques for better results (echo-guided puncture, shockwave). (Abstract) 2023; PCR-CIT China Chengdu Valves 2023.
34. Yin WH, Lee YT, Tsao TP, Wei J. Thirty-day Remote Electrocardiogram Screening in Patients undergoing Transcatheter Aortic Valve Replacement. (Abstract) 2023; PCR London Valves 2023.
35. Yin WH. Transcatheter treatment of failed mitral bioprosthesis. (Abstract) 2023; APCASH 2023.
36. Yin WH. 2024 Updates in the Management of CHIP Patients: Addressing the high-risk valvular patient with comorbid coronary disease. (Abstract) 2024; Singapore LIVE 2024.
37. Yin WH. Mastering techniques from basic to complex - TAVI basics: vascular access and closure. (Abstract) 2024; PCR Tokyo Valves 2024.
38. Yin WH, Lee YT, Lin HC, Tsao TP, Lee KC, Hsiung MC, Wei J. Proper sizing improves procedural outcomes of TAVR with both balloon-expandable and self-expanding valves for bicuspid aortic valve stenosis. (Abstract) 2024; PCR Tokyo Valves 2024.
39. Yin WH. Sizzling Contemporary Issues in Structural Heart Disease - How to Determine Optimal Implantation Depth in TAVR. (Abstract) 2024; MIS-Korea 2024.
40. Yin WH. Tips and Tricks in Bicuspid AS TAVR. (Abstract) 2024; China Valve Hangzhou 2024.
41. Yin WH. How to Treat Degenerated TAVI Valve? (Abstract) 2024; 29th TCTAP 2024.
42. Yin WH, Lee YT, Lee KC, Tsao TP, Wei J. Proper Sizing Takes into Consideration of Annular and Supra-Annular Planes and Calcium Distribution Can Improve Outcomes of Transcatheter Aortic Valve Replacement with Both Balloon-Expandable and Self-Expanding Valves. (Abstract) 2024; 29th TCTAP 2024.
43. Yin WH. LAMPOON technique improves outcomes of Transcatheter mitral valve-in-valve and valve-in-ring. (Abstract) 2024; EuroPCR 2024.
44. Yin WH. Next generation of TAVR procedure-ViV-TAVR and Redo-TAVR. (Abstract) 2024; The 18th Oriental Congress of Cardiology Together with The World Congress of Cardiology 2024.
45. Yin WH. Applications of LAMPOON Technology for TMVR. (Abstract) 2024; The 18th Oriental Congress of Cardiology Together with The World Congress of Cardiology 2024.
46. Yin WH. Patient management before during and after transcatheter tricuspid intervention. (Abstract) 2024; Beijing Valves 2024.
47. Yin WH. Breaking barriers between physicians and surgeons in the era of valve intervention therapy. (Abstract) 2024; Beijing Valves 2024.
48. Yin WH. Coronary-first Approach to Optimize Results of TAVR and Redo-TAVR. (Abstract) 2024; AP VALVES & STRUCTURAL HEART 2024.
中文著作:
1. 殷偉賢. 台灣心衰治療現狀. 福建省醫學會心血管病學分會第二十三次心血管病學術會議, 2019. (摘要)
2. 殷偉賢. TAVR使用於較年輕病人應考慮的事項. 福建省醫學會心血管病學分會第二十三次心血管病學術會議, 2019. (摘要)
3. 殷偉賢. 外科醫師婉拒的高危CHIP PCI. 海峽兩岸醫藥衛生交流協會心血管專業委員會第十屆年會, 2019. (摘要)
4. 殷偉賢. 二尖瓣膜閉鎖不全治療的新境界-Transcatheter mitral valve replacement: what is new? 臺灣醫學會第116屆總會, 2023. (摘要)
5. 賴旻, 邱尚志, 李佩珍, 殷偉賢, 林寬佳. 台灣小區域民眾就醫經驗之分析. 台灣衛誌 2023;42:651-662.
